OncoPep Revenue and Competitors
Estimated Revenue & Valuation
- OncoPep's estimated annual revenue is currently $1M per year.
- OncoPep's estimated revenue per employee is $77,500
- OncoPep's total funding is $28.4M.
Employee Data
- OncoPep has 13 Employees.
- OncoPep grew their employee count by 8% last year.
OncoPep's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder & CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Strategy Officer (CSO) | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Co-Chair | Reveal Email/Phone |
6 | Senior Scientist Immunology and Oncology | Reveal Email/Phone |
7 | Controller | Reveal Email/Phone |
8 | Senior Scientist Immunology and Oncology | Reveal Email/Phone |
OncoPep Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is OncoPep?
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell focused technologies are designed to be used on their own or in combination with other immunotherapeutics.
keywords:N/A$28.4M
Total Funding
13
Number of Employees
$1M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.8M | 13 | -19% | $3M |
#2 | $2.1M | 13 | N/A | N/A |
#3 | $0.4M | 13 | -7% | $71.8M |
#4 | $1.3M | 13 | -46% | $96.5M |
#5 | $1M | 13 | -50% | $200M |